Generic iron injection put to the test in healthy volunteers
NCT ID NCT07606105
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This Phase 1 trial is comparing a generic version of the iron injection ferric carboxymaltose to the brand-name drug Injectafer in 70 healthy adults. The goal is to see if the generic works the same way in the body and is safe. Participants receive a single dose of either drug and have their blood levels of iron measured over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ferric carboxymaltose (iron injection)
What this could lead to
If successful, this could show that the generic iron injection is equivalent to the brand-name drug, potentially offering a lower-cost treatment option for iron deficiency.
What could go wrong
This is an early-stage trial in healthy people, not patients. It only measures how the drug moves through the body, not whether it treats disease. The generic may still fail to show equivalence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Central Hospital Shandong Province
RECRUITINGJinan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••